Pfizer Share Holder Equity 2010-2024 | PFE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Pfizer share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Pfizer share holder equity for the quarter ending June 30, 2024 was $87.975B, a 11.4% decline year-over-year.
Pfizer share holder equity for 2023 was $89.288B, a 6.91% decline from 2022.
Pfizer share holder equity for 2022 was $95.916B, a 23.82% increase from 2021.
Pfizer share holder equity for 2021 was $77.462B, a 22.04% increase from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Pfizer share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Pfizer share holder equity for the quarter ending June 30, 2024 was $87.975B, a 11.4% decline year-over-year.
Pfizer share holder equity for 2023 was $89.288B, a 6.91% decline from 2022.
Pfizer share holder equity for 2022 was $95.916B, a 23.82% increase from 2021.
Pfizer share holder equity for 2021 was $77.462B, a 22.04% increase from 2020.